Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Weingartner

Showing results (121-130 of 151) with videos related to

Pageof 16
Sort By:
Psychopharmacology|January 1, 1988
Intravenous nicotine in Alzheimer's disease: a pilot studyP A Newhouse, T Sunderland, P N Tariot, et al.
The American Journal of Psychiatry|October 1, 1990
Cognitive effects of corticosteroidsO M Wolkowitz, V I Reus, H Weingartner, et al.
Biological Psychiatry|January 1, 1997
Minimal effects of dextroamphetamine on scopolamine-induced cognitive impairments in humansR Martinez, S E Molchan, B A Lawlor, et al.
Journal of the American Geriatrics Society|August 1, 1988
High-dose naloxone in older normal subjects: implications for Alzheimer's diseaseP N Tariot, M Gross, T Sunderland, et al.
Psychopharmacology|January 1, 1987
Cognitive effects of L-deprenyl in Alzheimer's diseaseP N Tariot, T Sunderland, H Weingartner, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1986
Pharmacologic modelling of Alzheimer's diseaseT Sunderland, P N Tariot, H Weingartner, et al.
Archives of General Psychiatry|October 1, 1988
Multiple-dose arecoline infusions in Alzheimer's diseaseP N Tariot, R M Cohen, J A Welkowitz, et al.
Annals of Neurology|February 1, 1984
Central nervous system catecholamine metabolism in Korsakoff's psychosisP R Martin, H Weingartner, E K Gordon, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 1, 1995
Fluvoxamine treatment of alcoholic amnestic disorderP R Martin, B Adinoff, E Lane, et al.
Journal of Abnormal Psychology|February 1, 1980
Cognitive processes in normal and hyperactive children and their response to amphetamine treatmentH Weingartner, J L Rapoport, M S Buchsbaum, et al.
Pageof 16

Showing results (121-130 of 151) with videos related to

Sort By:
Pageof 16
Psychopharmacology|January 1, 1988
Intravenous nicotine in Alzheimer's disease: a pilot studyP A Newhouse, T Sunderland, P N Tariot, et al.
The American Journal of Psychiatry|October 1, 1990
Cognitive effects of corticosteroidsO M Wolkowitz, V I Reus, H Weingartner, et al.
Biological Psychiatry|January 1, 1997
Minimal effects of dextroamphetamine on scopolamine-induced cognitive impairments in humansR Martinez, S E Molchan, B A Lawlor, et al.
Journal of the American Geriatrics Society|August 1, 1988
High-dose naloxone in older normal subjects: implications for Alzheimer's diseaseP N Tariot, M Gross, T Sunderland, et al.
Psychopharmacology|January 1, 1987
Cognitive effects of L-deprenyl in Alzheimer's diseaseP N Tariot, T Sunderland, H Weingartner, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1986
Pharmacologic modelling of Alzheimer's diseaseT Sunderland, P N Tariot, H Weingartner, et al.
Archives of General Psychiatry|October 1, 1988
Multiple-dose arecoline infusions in Alzheimer's diseaseP N Tariot, R M Cohen, J A Welkowitz, et al.
Annals of Neurology|February 1, 1984
Central nervous system catecholamine metabolism in Korsakoff's psychosisP R Martin, H Weingartner, E K Gordon, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 1, 1995
Fluvoxamine treatment of alcoholic amnestic disorderP R Martin, B Adinoff, E Lane, et al.
Journal of Abnormal Psychology|February 1, 1980
Cognitive processes in normal and hyperactive children and their response to amphetamine treatmentH Weingartner, J L Rapoport, M S Buchsbaum, et al.
Pageof 16